SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-138192
Filing Date
2016-08-09
Accepted
2016-08-09 11:28:11
Documents
60
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11655_110q.htm 10-Q 951463
2 EX-31.1 a16-11655_1ex31d1.htm EX-31.1 9498
3 EX-31.2 a16-11655_1ex31d2.htm EX-31.2 9493
4 EX-32.1 a16-11655_1ex32d1.htm EX-32.1 8272
  Complete submission text file 0001104659-16-138192.txt   6440456

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fold-20160630.xml EX-101.INS 1471122
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20160630.xsd EX-101.SCH 44218
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20160630_cal.xml EX-101.CAL 58278
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20160630_def.xml EX-101.DEF 227789
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fold-20160630_lab.xml EX-101.LAB 465980
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20160630_pre.xml EX-101.PRE 389932
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 161816828
SIC: 2834 Pharmaceutical Preparations